<DOC>
	<DOCNO>NCT00966238</DOCNO>
	<brief_summary>A multi-center , open-label , escalate dose-ranging study ass safety , reactogenicity , immunogenicity four different VAX125 vaccine dose ; 0.5 µg , 1.0 µg , 2.0 µg , 3.0 µg , deliver i.m . single dose vaccination Day 0 . Hypothesis : VAX125 safe immunogenic one dose test .</brief_summary>
	<brief_title>Safety Immunogenicity VAX125 Influenza Vaccine Community-living Adults &gt; = 65 Years Age</brief_title>
	<detailed_description>A total 80 community-living adult ≥65 year age enrol across four dose group . Following vaccination , subject remain study site least 30 minute observe immediate reactogenicity complaint associate Day 0 vaccination . Subjects also evaluate clinic visit Study Days 1 , 7 , 14 , 28 follow vaccination . In addition , safety follow-up telephone contact occur post vaccination Day 3 . There 20 subject per dose group . Up 3 study site enroll 6-10 subject per dose group two-day enrollment period . Progression next high dose group take place Safety Monitoring Committee ( SMC ) assessment 30 ( +15 ) minute , Day 0 , Day 1 post vaccination safety data ; Day 3 telephone report : Day 0 Day 1 serum C-reactive protein ( CRP ) result conclude low dose well tolerate .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult men woman age 65 old ; female subject must post menopausal . Live community , independently assist living environment Based result Short Portable Mental Status Questionnaire ( SPMSQ ) , rat normal great mild severity dementia . As defined Canadian Study Health Aging Clinical Frailty Scale ( CSHACFS ) , fitness range fit mildly frail ; Classes 1 5 7 . Healthy volunteer , determine medical history , physical examination ( PE ) , vital sign , clinical safety laboratory examination . Able comprehend study requirement , agree provision , ability adhere provision study , give write informed consent prior study entry . Willing receive unlicensed ( VAX125 ) vaccine give i.m . injection . Willing provide multiple blood specimen collect venipuncture . Persons opinion Investigator , psychiatric illness , chronic illness ( e.g. , diabetes liver kidney disease ) , take concomitant therapy condition would interfere subject 's participation study interpretation study result . Persons cancer receive treatment cancer within three year ( person history cancer diseasefree without treatment three year eligible . Persons impair immune responsiveness ( cause ) , include diabetes mellitus . Persons presently receive recent history receiving ( within past six month ) medication therapeutic modality affect immune system allergy shot , immune globulin , interferon , immunomodulators , radiation therapy , cytotoxic drug drug know frequently associate significant major organ toxicity , systemic corticosteroid ( oral injectable ) . Inhaled topical corticosteroid allow . Persons prior serious reaction influenza vaccine . Persons history anaphylactictype reaction inject vaccine . Persons history drug chemical abuse year prior screen . Persons currently participate another research study involve study medication ( drug vaccine ) participate within 30 day vaccination . Persons receive blood blood product within eight week prior vaccination plan receive blood blood product study period . Persons donate blood blood product within eight week prior vaccination plan donate time study . Persons acute disease within 72 hour prior vaccination define presence moderate severe illness determine Investigator medical history physical examination . Vaccination delay subject recover . Persons significant cardiovascular disease e.g. , New York Heart Associate ( NYHA ) Class 3 4 congestive heart failure ; myocardial infarction within past six month ; unstable angina , coronary angioplasty within past six month ; uncontrolled ventricular cardiac arrhythmia ; rest heart rate ( HR ) &gt; 100 beat per minute ( bpm ) Persons history chronic obstructive pulmonary disease history lung disease .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>influenza</keyword>
	<keyword>vaccine</keyword>
</DOC>